The global Mammography market gathered revenue around USD 2.1 Billion in 2020 and market is set to grow USD 4.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 11.2% during the prediction period 2021 to 2027.
Growth Factors:
The rising prevalence of breast cancer and increasing demand for early-stage diagnosis amongst patients are some of the key factors anticipated to drive demand for breast cancer diagnostic devices over the forecast period. Increased access to breast cancer screening systems and growing government initiatives to support clinical interpretation are some of the pivotal factors expected to propel market growth. For instance, the Health Resources and Services Administration (HRSA) had introduced a healthcare program to increase the screening procedures in medically underserved areas.
The market growth can be attributed to the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of microcalcifications in breast tissue. Some significant organizations such as the National Breast Cancer Foundation, CDC, and Breast Cancer Organization are promoting the early diagnosis of mammary gland calcification, which is one of the crucial factors expected to drive the demand over the forecast period.
Based on a report published by the National Cancer Institute in 2015, it was stated that the proportion of women aged 45 to 65 years had increased to 82.1% in breast cancer screening. Major mammography manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years.
The introduction of new products in the market is expected to boost the adoption rate among end-users. The earlier generations of mammography systems provided 2D images of the breast, which limits the interpretation quality. 2D mammography systems provide Craniocaudal (CC) and Mediolateral-Oblique (MLO) images. The flat nature of these images makes it difficult for physicians to interpret images and identify tumors due to overlapping of tissues and calcifications, which masks cancerous lesions. With the introduction of new 3D-based technology called Digital Breast Tomosynthesis (DBT), it is possible to obtain a 3D image of the breast. This allows radiologists to scan the breast slice by slice and identify abnormalities, which would be obscured in 2D images.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Mammography market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Mammography market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 4.0 Billion by 2027 |
Growth Rate | CAGR of 11.2% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Product, technology And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Hologic; Fujifilm; Siemens Healthcare; Phillips Healthcare; Toshiba Medical Systems, GE Healthcare; Metaltronica; I.M.S. Srl. |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Mammography market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America dominated the market and accounted for the largest revenue share of 38.2% in 2020. The region is expected to exhibit a considerable growth rate over the forecast period. The rising incidence of breast cancer is one of the major factors driving the market in the region. In addition, the presence of highly developed healthcare infrastructure and increasing healthcare spending are among factors anticipated to drive the market in the region over the forecast period.
In Asia Pacific, the market is anticipated to witness the fastest growth over the forecast period. The presence of developing countries, such as China, and Japan, is anticipated to boost market growth in Asia Pacific region. In addition, key players are making constant efforts to enter emerging markets of Asia Pacific, which is expected to boost the market over the forecast period.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Mammography Market include: Hologic; Fujifilm; Siemens Healthcare; Phillips Healthcare; Toshiba Medical Systems, GE Healthcare; Metaltronica; I.M.S. Srl
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Mammography market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Mammography market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Mammography markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Mammography market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Mammography Market, By Product
7.1. Mammography Market, By Product, 2021-2027
7.1.1. Film Screen Systems
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Digital Systems
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Analog Systems
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Biopsy Systems
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. 3D Systems
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Mammography Market, By Technology
8.1. Mammography Market, By Technology, 2021-2027
8.1.1. Breast Tomosynthesis
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. CAD
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Digital
8.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Mammography Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Product (2016-2027)
9.1.2. Market Revenue and Forecast, By Technology (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Product (2016-2027)
9.1.3.2. Market Revenue and Forecast, By Technology (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Product (2016-2027)
9.1.4.2. Market Revenue and Forecast, By Technology (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Product (2016-2027)
9.2.2. Market Revenue and Forecast, By Technology (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Product (2016-2027)
9.2.3.2. Market Revenue and Forecast, By Technology (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Product (2016-2027)
9.2.4.2. Market Revenue and Forecast, By Technology (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Product (2016-2027)
9.2.5.2. Market Revenue and Forecast, By Technology (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Product (2016-2027)
9.2.6.2. Market Revenue and Forecast, By Technology (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Product (2016-2027)
9.3.2. Market Revenue and Forecast, By Technology (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Product (2016-2027)
9.3.3.2. Market Revenue and Forecast, By Technology (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Product (2016-2027)
9.3.4.2. Market Revenue and Forecast, By Technology (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
9.3.5.2. Market Revenue and Forecast, By Technology (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Product (2016-2027)
9.3.6.2. Market Revenue and Forecast, By Technology (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Product (2016-2027)
9.4.2. Market Revenue and Forecast, By Technology (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Product (2016-2027)
9.4.3.2. Market Revenue and Forecast, By Technology (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Product (2016-2027)
9.4.4.2. Market Revenue and Forecast, By Technology (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
9.4.5.2. Market Revenue and Forecast, By Technology (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Product (2016-2027)
9.4.6.2. Market Revenue and Forecast, By Technology (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Product (2016-2027)
9.5.2. Market Revenue and Forecast, By Technology (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Product (2016-2027)
9.5.3.2. Market Revenue and Forecast, By Technology (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Product (2016-2027)
9.5.4.2. Market Revenue and Forecast, By Technology (2016-2027)
Chapter 10. Company Profiles
10.1. Hologic
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Fujifilm
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Siemens Healthcare
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Phillips Healthcare;
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Toshiba Medical Systems
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. GE Healthcare
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Metaltronica
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. I.M.S. Srl
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms